This Penny Stock Has Wall Street Attention and Is Up Nearly 600%

ImmunoPrecise Antibodies (IPA) shows strong technical momentum, hitting new 52-week highs on Aug. 21. The stock maintains a 100% “Buy” opinion from Barchart. Shares are up an impressive 565% in 2025. Despite bullish analyst sentiment, IPA is volatile and speculative. Today’s Featured Stock Valued at only $121 million, ImmunoPrecise Antibodies...